Abstract
AbstractRecent work demonstrates that epidermal keratinocytes are critical for normal touch sensation. However, it is unknown if keratinocytes contribute to touch evoked pain and hypersensitivity following tissue injury. Here, we used inhibitory optogenetic and chemogenetic techniques to determine the extent to which keratinocyte activity contributes to the severe neuropathic pain that accompanies chemotherapeutic treatment. We found that keratinocyte inhibition largely alleviates paclitaxel-induced mechanical hypersensitivity. Furthermore, we found that paclitaxel exposure sensitizes mouse and human keratinocytes to mechanical stimulation through the keratinocyte mechanotransducer Piezo1. These findings demonstrate the contribution of non-neuronal cutaneous cells to neuropathic pain and pave the way for the development of new pain-relief strategies that target epidermal keratinocytes and Piezo1.SummarySensitization of the keratinocyte mechanotransducer Piezo1 drives paclitaxel-induced touch pain.
Publisher
Cold Spring Harbor Laboratory
Reference69 articles.
1. Update on taxane development: new analogs and new formulations;Drug Des. Devel. Ther,2012
2. Paclitaxel: a review of adverse toxicities and novel delivery strategies
3. Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
4. Dermatological adverse events with taxane chemotherapy;Eur. J. Dermatol. EJD,2016
5. A meta-analysis of the incidence and risk of skin toxicity with nab-paclitaxel and paclitaxel in cancer treatment;Am. J. Transl. Res,2023
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献